Study links perimenopause to accelerated fat mass gains, lean mass losses

March 21, 2019

FINDINGS

The menopause transition, also known as perimenopause, is the time in a woman's life when hormonal changes lead to irregular menstruation, hot flashes and other symptoms leading up to menopause, when menstruation stops altogether. The researchers found that women undergoing perimenopause lost lean body mass and more than doubled their fat mass. The women's lean and fat mass remained stable after the transition to menopause. The researchers also noted ethnic/racial differences in the impact of menopause on body composition.

BACKGROUND

The relationship between menopause and changes in body composition has not been well understood. While some smaller studies have looked at the impact of the menopause transition on body composition and weight, the Study of Women's Health Across the Nation provides sufficiently voluminous and detailed data to enable researchers to disentangle the effects of chronological aging and reproductive aging.

METHOD

The researchers examined 18 years of data from the women's health study, assessing women's body composition using a model that gave them a picture of that composition from the time before and after their final menstrual period, accounting for race/ethnicity and hormone therapy.

IMPACT

Until now, there was no proof that menopause leads to gains in fat mass or losses of lean mass. The study demonstrates that a simple measurement of body weight does not illustrate what is happening "under the skin." Other research has found that, as women grow older, body mass index becomes a less reliable predictor of conditions such as diabetes or cardiovascular disease. These menopause-related shifts in fat and lean mass may be one of the reasons for the decline in the ability to predict the capacity of body mass index in older women.
-end-
AUTHORS

Dr. Gail Greendale, MeiHua Huang, Weijuan Han and Dr. Arun Karlamangla of UCLA; Barbara Sternfeld and Sheng-Fang Jiange of Kaiser Permanente; Carrie Karvonen-Gutierrez of the University of Michigan; Kristine Ruppert and Jane Cauley of the University of Pittsburgh; Dr. Joel Finkelstein of Massachusetts General Hospital.

JOURNAL

The article was published in the journal JCI Insight.

FUNDING

The National Institutes of Health; Department of Health and Human Services, through the National Institute on Aging; the National Institute of Nursing Research; and the National Institutes of Health Office of Research on Women's Health supported this study.

Media Contact:

Enrique Rivero
310-267-7120
erivero@mednet.ucla.edu

University of California - Los Angeles Health Sciences

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.